Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.960
-0.060 (-1.99%)
At close: Sep 5, 2025, 4:00 PM
2.980
+0.020 (0.68%)
After-hours: Sep 5, 2025, 7:53 PM EDT
Akebia Therapeutics Employees
Akebia Therapeutics had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$1,125,597
Profits / Employee
-$201,569
Market Cap
784.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 14 | 8.38% |
| Dec 31, 2023 | 167 | -38 | -18.54% |
| Dec 31, 2022 | 205 | -221 | -51.88% |
| Dec 31, 2021 | 426 | 46 | 12.11% |
| Dec 31, 2020 | 380 | 20 | 5.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AKBA News
- 1 day ago - Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Akebia Therapeutics: Post-Earnings Dip Looks Like A Discounted Entry Ahead Of A Vafseo Inflection - Seeking Alpha
- 9 days ago - Akebia Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Akebia Therapeutics and Innovative Renal Care Announce Nationwide Availability of Vafseo® (vadadustat) Across All IRC Dialysis Clinics - GlobeNewsWire
- 4 weeks ago - Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Akebia Therapeutics to Present at Canaccord Genuity's 45th Annual Growth Conference - GlobeNewsWire